Top 10 Companies in the (S)-1-(3-Nitrophenyl)propanol (CAS 188770-83-4) Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

MARKET INSIGHTS

Global (S)-1-(3-Nitrophenyl)propanol (CAS 188770-83-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-1-(3-Nitrophenyl)propanol is a chiral secondary alcohol bearing a nitro substituent at the meta position of the phenyl ring, with the molecular formula C… and a molecular weight of approximately 181.19 g/mol. As an enantiomerically pure compound, it serves as a critical chiral building block and intermediate in asymmetric synthesis, particularly valued in the pharmaceutical and fine chemical industries for its well‑defined stereochemical configuration.

The market is gaining steady momentum, driven by the growing demand for chiral intermediates in active pharmaceutical ingredient (API) synthesis and the broader expansion of asymmetric chemistry applications. Furthermore, increasing research activities in drug discovery – particularly in the development of adrenergic and cardiovascular therapeutics – continue to support demand. Key chemical suppliers and specialty fine chemical manufacturers operating globally are expanding their chiral compound portfolios, reinforcing consistent supply chains and quality standards for this compound.

(S)-1-(3-Nitrophenyl)propanol (CAS 188770-83-4) Market – View in Detailed Research Report

Top 10 Companies

1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: High‑purity chiral building blocks for API synthesis

Merck’s vertically integrated manufacturing and robust R&D portfolio enable a consistent supply of enantiomerically pure intermediates to global pharmaceutical developers. The company’s commitment to green chemistry is reflected in its use of renewable feedstocks and waste‑minimization protocols.

Sustainability Initiatives:

• Integration of renewable raw materials
• Waste‑reduction through process intensification
• Carbon‑neutral production targets

2. Thermo Fisher Scientific

Headquarters: Waltham, USA
Key Offering: Custom chiral synthesis services and analytical solutions

Thermo Fisher supports pharmaceutical R&D with on‑demand chiral synthesis and advanced analytical tools, ensuring rapid validation of enantiomeric purity. Its global network delivers timely support to research laboratories and early‑stage manufacturers.

Sustainability Initiatives:

• Circular chemistry programs reducing hazardous reagents
• Energy‑efficient manufacturing facilities
• Partnerships with academic institutions for green chemistry research

3. PharmaBlock Sciences

Headquarters: Shenzhen, China
Key Offering: Cost‑effective production of chiral intermediates

Leveraging multiple Chinese sites, PharmaBlock delivers scalable, high‑purity chiral alcohols to the domestic and regional pharmaceutical market. Its production strategy focuses on rapid scale‑up and local supply chain integration.

Sustainability Initiatives:

• Use of renewable feedstocks in synthesis
• Implementation of closed‑loop water systems
• Local sourcing to reduce transportation emissions

4. Enamine

Headquarters: Kyiv, Ukraine
Key Offering: Enzyme‑mediated chiral synthesis and custom routes

Enamine’s expertise in biocatalysis allows the production of (S)-configured alcohols with high enantiomeric excess while minimizing hazardous reagents. The company offers flexible small‑batch solutions for research and early‑stage development.

Sustainability Initiatives:

• Biocatalytic processes that reduce waste and energy use
• Use of biodegradable solvents where feasible
• Participation in international green chemistry initiatives

5. SynQuest Laboratories

Headquarters: San Diego, USA
Key Offering: Small‑batch, high‑purity chiral intermediates

SynQuest delivers tailored chiral building blocks for early‑phase drug discovery, with a focus on GMP‑aligned production and rapid turnaround. Its lean manufacturing approach reduces resource consumption.

Sustainability Initiatives:

• Optimized process flows for lower energy consumption
• Recycling of solvents and reagents
• Transparent environmental reporting

6. Apollo Scientific

Headquarters: London, UK
Key Offering: Technical‑grade chiral building blocks

Apollo supplies high‑purity materials to academic and industrial laboratories, emphasizing technical grade options for research applications. The company incorporates recycled solvents in its production pipeline.

Sustainability Initiatives:

• Use of recycled solvents and materials
• Energy‑efficient manufacturing practices
• Engagement in sustainability reporting frameworks

7. Biosynth AG

Headquarters: Basel, Switzerland
Key Offering: Advanced biocatalytic production of chiral alcohols

Biosynth employs engineered enzymes to achieve high yield and enantiomeric excess, supporting scalable production of (S)-1-(3‑nitrophenyl)propanol. The company’s processes generate minimal waste and operate under mild conditions.

Sustainability Initiatives:

• Biocatalytic routes reducing hazardous by‑products
• Closed‑loop water and energy systems
• Collaboration with research institutes on green chemistry

8. Combi-Blocks

Headquarters: New York, USA
Key Offering: Modular chiral building blocks for synthetic chemistry

Combi-Blocks offers a modular platform that enables rapid scaffold construction, reducing the need for multiple synthetic steps. The modular approach lowers material waste and shortens development timelines.

Sustainability Initiatives:

• Design‑for‑efficiency to minimize excess reagents
• Use of greener solvents in modular reactions
• Support for digital workflow integration

9. Oakwood Products

Headquarters: Houston, USA
Key Offering: Technical‑grade chiral intermediates

Oakwood provides cost‑effective, technical‑grade chiral building blocks for research laboratories, with an emphasis on efficient logistics and rapid delivery.

Sustainability Initiatives:

• Optimized supply chain to reduce carbon footprint
• Efficient use of raw materials
• Compliance with environmental regulations

10. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Broad catalog of chiral reagents and intermediates

TCI serves a global customer base with a wide range of chiral building blocks, supporting diverse synthetic routes. The company invests in green chemistry initiatives across its manufacturing sites.

Sustainability Initiatives:

• Green chemistry research and development
• Energy‑efficient production facilities
• Commitment to ISO 14001 environmental standards

Download FREE Sample Report

Get Full Report

Market Outlook

The projected trajectory of the (S)-1-(3‑nitrophenyl)propanol market reflects a consistent rise in demand driven by the pharmaceutical sector’s focus on single‑enantiomer drugs and the expanding portfolio of chiral intermediates. Supply chains are becoming more resilient as specialty manufacturers invest in scalable production and advanced quality controls, ensuring that high‑purity standards are met across regions. The convergence of regulatory requirements and technological advances positions the market for steady growth, with a notable emphasis on process efficiency and supply stability.

Future Trends

Key developments that will shape the market include the growing adoption of biocatalytic routes, which offer lower environmental impact and higher enantiomeric control. Digitalization of supply chains and real‑time analytics will enable faster validation and reduced lead times. Regulatory momentum toward single‑enantiomer approvals will further elevate the importance of chiral intermediates. Additionally, emerging applications in agrochemical and material science research are beginning to diversify the demand base, potentially unlocking new market segments over the medium term.